Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 20/20 | 0.46 |
| ▸ | CTSD | P07339 | 7/20 | 0.45 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | BACE2 | Q9Y5Z0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2371419 | 1.00 | BACE1 (0.46) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL15418908 | 0.90 | BACE1 (0.48) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL15418909 | 0.90 | BACE1 (0.48) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL2521694 | 0.85 | BACE1 (0.49) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL2521696 | 0.85 | BACE1 (0.49) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL11894446 | 0.74 | BACE1 (0.44) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL11894445 | 0.74 | BACE1 (0.44) | BACE1CTSDKCNH2BACE2 | |
| SCHEMBL2372292 | 0.72 | BACE1 (0.45) | BACE1CTSDKCNH2 | |
| SCHEMBL2528274 | 0.71 | BACE1 (0.55) | BACE1CTSDKCNH2 | |
| SCHEMBL2528271 | 0.71 | BACE1 (0.55) | BACE1CTSDKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2547686-A1 | AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE | Amgen Inc. (US) | 2013-01-23 | — | — | EP | disclosed |
| WO-2011115928-A1 | AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE | AMGEN INC. (US) | 2011-09-22 | — | — | WO | disclosed |